Literature DB >> 9774475

Distinct cytoplasmic regions of the prolactin receptor are required for prolactin-induced calcium entry.

B Sorin1, O Goupille, A M Vacher, J Paly, J Djiane, P Vacher.   

Abstract

Two cytoplasmic regions of the prolactin (PRL) receptor are well documented for their participation in PRL signal transduction, the membrane proximal box 1 and the COOH-terminal region. In order to study the role of these regions in PRL-induced Ca2+ increase, we use Chinese hamster ovary (CHO) cells stably transfected with mutated PRL receptor cDNA. These cells express the long form of PRL receptor deleted from box 1 (CHO Delta1 cells) or the 141 amino acids of the COOH-terminal region (CHO H3 cells). The patch-clamp technique in "whole-cell" configuration and microfluorimetric techniques were used singly or in combination. Data obtained for these cells were compared with those we have recently published using CHO cells expressing the wild-type long form of the PRL receptor (CHO TSE32). In contrast to CHO TSE32 cells, exposure of CHO Delta1 or H3 cells to PRL (0.05-50 nM) did not modify [Ca2+]i. We have previously shown that the PRL-induced calcium influx via voltage-insensitive, Ca2+ channels was due to the activation of tyrosine kinase-dependent K+ channels that hyperpolarize the CHO TSE32 cell membrane (hyperpolarization-driven Ca2+ influx). Therefore, two events are involved in PRL-induced Ca2+ changes (i) JAK2-activation of K+ channels and (ii) intracellular messenger-opening of Ca2+ channels. In CHO Delta1 cells, PRL (0.05-50 nM) neither hyperpolarized the membrane potential nor stimulated the JAK2-dependent K+ current, confirming the pivotal role played by box 1/JAK2 in the PRL-induced activation of K+ channels. However, when these cells were voltage-clamped below the resting membrane potential, application of 5 nM PRL resulted in an increase in Ca2+ influx. Therefore, box 1/JAK2 was not involved in the opening of these Ca2+ channels. In CHO H3 cells, 5 nM PRL activated the K+ current and hyperpolarized the membrane potential without any effect on [Ca2+]i. Moreover, PRL was also ineffective on CHO H3 cells voltage-clamped below the resting membrane potential. Therefore, the COOH-terminal region is involved in the production of the intracellular messenger that opens voltage-independent Ca2+ channels. We conclude from these findings that box 1 and COOH-terminal regions are both needed for PRL-induced Ca2+ changes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9774475     DOI: 10.1074/jbc.273.43.28461

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  Intermediate Ca2+-sensitive K+ channels are necessary for prolactin-induced proliferation in breast cancer cells.

Authors:  Malika Faouzi; Valérie Chopin; Ahmed Ahidouch; Halima Ouadid-Ahidouch
Journal:  J Membr Biol       Date:  2010-02-23       Impact factor: 1.843

2.  CD95 triggers Orai1-mediated localized Ca2+ entry, regulates recruitment of protein kinase C (PKC) β2, and prevents death-inducing signaling complex formation.

Authors:  Nadine Khadra; Laurence Bresson-Bepoldin; Aubin Penna; Benjamin Chaigne-Delalande; Bruno Ségui; Thierry Levade; Anne-Marie Vacher; Josy Reiffers; Thomas Ducret; Jean-François Moreau; Michael D Cahalan; Pierre Vacher; Patrick Legembre
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

3.  Prolactin stimulates cell proliferation through a long form of prolactin receptor and K+ channel activation.

Authors:  Fabien Van Coppenolle; Roman Skryma; Halima Ouadid-Ahidouch; Christian Slomianny; Morad Roudbaraki; Philippe Delcourt; Etienne Dewailly; Sandrine Humez; Alexandre Crépin; Isabelle Gourdou; Jean Djiane; Jean-Louis Bonnal; Brigitte Mauroy; Natalia Prevarskaya
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

4.  The antidepressant fluoxetine induces necrosis by energy depletion and mitochondrial calcium overload.

Authors:  Emilie Charles; Mehdi Hammadi; Philippe Kischel; Vanessa Delcroix; Nicolas Demaurex; Cyril Castelbou; Anne-Marie Vacher; Anne Devin; Thomas Ducret; Paula Nunes; Pierre Vacher
Journal:  Oncotarget       Date:  2017-01-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.